Endpoints That Matter

July 23, 2020

Parexel’s Andreas Reiff, VP, Global TA Head, Inflammation/Immunology talks with Julie Stover, Senior Director, Solution Consulting, also from Parexel, about her journey being diagnosed with Ankylosing spondylitis (AS) and how capturing meaningful endpoints during the drug development process means a better quality of life for patients like her.

Previous Article
Top 10 Myths About Working with the FDA for an Oncology Drug Approval
Top 10 Myths About Working with the FDA for an Oncology Drug Approval

Amy McKee, Vice President Regulatory Consulting Services, addresses some of the most common misconceptions ...

Next Article
The future is now: Decentralized clinical trials during the pandemic and beyond
The future is now: Decentralized clinical trials during the pandemic and beyond

Enabling patients to participate in clinic trials from home is both important to maintain patient safety an...

Contact Us with your Biotech needs!

Email Us